Hitting cancer early: AstraZeneca’s bid to outmaneuver rivals
AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might...
Read MorePosted by Reuters | Jul 6, 2018 | World News |
AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might...
Read MorePosted by Reuters | Jul 6, 2018 | World News |
U.S. President Donald Trump’s threat to block Chinese investment in U.S. companies could be trouble for a number of American automotive and technology companies using Chinese funds to develop electric and self-driving cars and...
Read MorePosted by Reuters | Jul 6, 2018 | World News |
Shares in Germany’s troubled Deutsche Bank jumped by up to 6 percent on Friday following a magazine report that JPMorgan and Industrial and Commercial Bank of China (ICBC) may be interested in taking a...
Read MorePosted by Reuters | Jul 6, 2018 | World News |
Oil slipped toward $77 a barrel on Friday, under pressure from higher Saudi production and trade tensions between the United States and China, although oil supply disruptions lent...
Read MorePosted by Reuters | Jul 6, 2018 | World News |
Switzerland’s second-biggest bank Credit Suisse has carved out a new role to lead its handling of sexual harassment claims and examine group-wide policies, its CEO told employees on...
Read More